Follow
Sheldon Tobe
Sheldon Tobe
University of Toronto, Northern Ontario School of Medicine
Verified email at sunnybrook.ca
Title
Cited by
Cited by
Year
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ...
The Lancet 394 (10193), 121-130, 2019
21832019
Cardiorenal end points in a trial of aliskiren for type 2 diabetes
HH Parving, BM Brenner, JJV McMurray, D De Zeeuw, SM Haffner, ...
New England Journal of Medicine 367 (23), 2204-2213, 2012
16142012
Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin
A Levin, CR Thompson, J Ethier, EJF Carlisle, S Tobe, D Mendelssohn, ...
American Journal of Kidney Diseases 34 (1), 125-134, 1999
12981999
Hypertension Canada’s 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children
KA Nerenberg, KB Zarnke, AA Leung, K Dasgupta, S Butalia, K McBrien, ...
Canadian Journal of Cardiology 34 (5), 506-525, 2018
6952018
Guidelines for the management of chronic kidney disease
A Levin, B Hemmelgarn, B Culleton, S Tobe, P McFarlane, M Ruzicka, ...
Cmaj 179 (11), 1154-1162, 2008
6352008
Hypertension Canada's 2016 Canadian hypertension education program guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of …
AA Leung, K Nerenberg, SS Daskalopoulou, K McBrien, KB Zarnke, ...
Canadian Journal of Cardiology 32 (5), 569-588, 2016
5372016
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ...
The Lancet 394 (10193), 131-138, 2019
5232019
The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis
M Roerecke, J Kaczorowski, SW Tobe, G Gmel, OSM Hasan, J Rehm
The Lancet Public Health 2 (2), e108-e120, 2017
4902017
The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension
SS Daskalopoulou, DM Rabi, KB Zarnke, K Dasgupta, K Nerenberg, ...
Canadian Journal of Cardiology 31 (5), 549-568, 2015
4872015
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
HJL Heerspink, HH Parving, DL Andress, G Bakris, R Correa-Rotter, ...
The Lancet 393 (10184), 1937-1947, 2019
4842019
Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10
UI Scholl, M Choi, T Liu, VT Ramaekers, MG Häusler, J Grimmer, ...
Proceedings of the National Academy of Sciences 106 (14), 5842-5847, 2009
4812009
Hypertension Canada’s 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children
DM Rabi, KA McBrien, R Sapir-Pichhadze, M Nakhla, SB Ahmed, ...
Canadian Journal of Cardiology 36 (5), 596-624, 2020
4672020
Hypertension Canada's 2017 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults
AA Leung, SS Daskalopoulou, K Dasgupta, K McBrien, S Butalia, ...
Canadian Journal of Cardiology 33 (5), 557-576, 2017
4182017
Measurement of blood pressure in the office: recognizing the problem and proposing the solution
MG Myers, M Godwin, M Dawes, A Kiss, SW Tobe, J Kaczorowski
Hypertension 55 (2), 195-200, 2010
3802010
The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension
K Dasgupta, RR Quinn, KB Zarnke, DM Rabi, P Ravani, ...
Canadian Journal of Cardiology 30 (5), 485-501, 2014
3742014
Conventional versus automated measurement of blood pressure in primary care patients with systolic hypertension: randomised parallel design controlled trial
MG Myers, M Godwin, M Dawes, A Kiss, SW Tobe, FC Grant, ...
Bmj 342, 2011
3442011
Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter
A Levin, O Djurdjev, B Barrett, E Burgess, E Carlisle, J Ethier, K Jindal, ...
American Journal of kidney diseases 38 (6), 1398-1407, 2001
3402001
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2–therapy
DG Hackam, NA Khan, BR Hemmelgarn, SW Rabkin, RM Touyz, ...
Canadian Journal of Cardiology 26 (5), 249-258, 2010
3132010
The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy
D De Zeeuw, B Coll, D Andress, JJ Brennan, H Tang, M Houser, ...
Journal of the American Society of Nephrology 25 (5), 1083-1093, 2014
3042014
The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension
DG Hackam, RR Quinn, P Ravani, DM Rabi, K Dasgupta, ...
Canadian Journal of Cardiology 29 (5), 528-542, 2013
2992013
The system can't perform the operation now. Try again later.
Articles 1–20